Goserelin plus tamoxifen versus tamoxifen alone in pre-or peri-menopausal patients with hormone receptor-positive early-stage breast cancer: A randomized, controlled clinical trial in China.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Zhejiang Cancer Hospital, Shanghai Sixth People's Hospital
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2627948817
